1. Home
  2. COHN vs CPHI Comparison

COHN vs CPHI Comparison

Compare COHN & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

N/A

Current Price

$12.84

Market Cap

32.9M

Sector

Finance

ML Signal

N/A

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.59

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
CPHI
Founded
1999
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.9M
31.2M
IPO Year
2003
2008

Fundamental Metrics

Financial Performance
Metric
COHN
CPHI
Price
$12.84
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.1K
10.0M
Earning Date
05-01-2026
05-11-2026
Dividend Yield
4.35%
N/A
EPS Growth
5537.50
N/A
EPS
0.42
N/A
Revenue
$275,564,000.00
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.07
N/A
Revenue Growth
246.19
N/A
52 Week Low
$9.19
$0.38
52 Week High
$32.60
$19.19

Technical Indicators

Market Signals
Indicator
COHN
CPHI
Relative Strength Index (RSI) 49.39 50.47
Support Level $12.84 $0.84
Resistance Level $14.50 N/A
Average True Range (ATR) 0.65 1.70
MACD -0.05 0.14
Stochastic Oscillator 36.18 5.62

Price Performance

Historical Comparison
COHN
CPHI

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: